Search This Blog

Monday, September 18, 2023

Cassava: Positive Interim Safety Review of Simufilam On-going Phase 3 in Alzheimer’s

 

  • An Independent Data and Safety Monitoring Board (DSMB) Recently Evaluated the Interim Patient Safety Database for Simufilam in On-Going Phase 3 Clinical Trials.

  • The DSMB Recommended the Phase 3 Trials of Simufilam Continue as Planned, Without Modification

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)